• Palbocent 125 mg (Palbociclib) Quick View
    • Palbocent 125 mg (Palbociclib) Quick View
    • ,

    • Palbocent 125 mg (Palbociclib)

    • Palbocent 125 mg (Palbociclib) is an innovative oral medication used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. Palbociclib, the active ingredient in Palbocent, is a selective inhibitor of cyclin-dependent kinases (CDK) 4 and 6, enzymes that play a crucial role in the growth and division of cancer cells. By blocking…
    • Read more